Muscle Invasive Bladder Cancer

Treatment of Invasive Bladder Cancer in the Elderly and Frail Patient

Dr. Jehonathan Pinthus presented “Treatment of Invasive Bladder Cancer in the Elderly and Frail Patient ” at the  International Bladder Cancer Update meeting on Tuesday, January 24, 2017.     Keywords: bladder cancer, BCG, CIS, chemotherapy, cystectomy, elderly, invasive, neoadjuvant, nonagenarians, TURBT How to cite: Pinthus, Jehonathan. “Treatment of Invasive Bladder Cancer in the Elderly and Frail Patient ” January 24, 2017. Accessed Dec 2017. https://grandroundsinurology.com/treatment-invasive-bladder-cancer-elderly-frail-patient   Transcript Treatment of Invasive Bladder Cancer in the Elderly and Frail Patient I think this is a very contemporary topic because we are living in an aging society. If you look here, and you know if you really want to...

Read More

Beyond Checkpoint Inhibition: New Therapeutic Approaches to Bladder Cancer

Dr. Daniel P. Petrylak presented “Beyond Checkpoint Inhibition: New Therapeutic Approaches to Bladder Cancer” at the International Bladder Cancer Update meeting on Tuesday, January 24, 2017.     Keywords: bladder cancer, chemotherapy, docetaxel, MTOR,  TORC1, TORC2, TSC, VEGFR  How to cite: Petrylak, Daniel P.  “Beyond Checkpoint Inhibition: New Therapeutic Approaches to Bladder Cancer” January 24, 2017. Accessed Dec 2017. https://grandroundsinurology.com/beyond-checkpoint-inhibition Transcript Beyond Checkpoint Inhibition: New Therapeutic Approaches to Bladder Cancer There are some patients of course who can’t receive cisplatin-based therapy, but not all patients are eligible for immune therapy. If they’ve had autoimmune diseases, if they’ve had psoriasis that requires that they go on systemic therapy, if...

Read More

Checkpoint Inhibitors

Dr. Daniel P. Petrylak presented “Checkpoint Inhibitors” at the International Bladder Cancer Update meeting on Tuesday, January 24, 2017. Keywords: bladder cancer, atezolizumab, chemotherapy, inhibitors, metastatic, pembrolizumab How to cite: Petrylak, Daniel P.  “Checkpoint Inhibitors” January 24, 2017. Accessed Dec 2017. https://grandroundsinurology.com/checkpoint-inhibitors Summary: Dr. Daniel P. Petrylak discusses urology practices moving from standard chemotherapy and toward studying checkpoint inhibitors’ efficacy when treating tumors, especially regarding bladder cancer. Checkpoint Inhibitors Edited Transcript: To get a sense of our starting point for this lecture, take a look at this graph. It shows survival curves for a patient with metastatic disease, treated with primary chemotherapy. You could substitute any cisplatin-based regimen...

Read More

Neoadjuvant and Adjuvant Chemotherapy in Bladder Cancer

Dr. Neal D. Shore presented “Neoadjuvant and Adjuvant Chemotherapy in Bladder Cancer” at the  International Bladder Cancer Update meeting on Tuesday, January 24, 2017.     Keywords: bladder cancer, adjuvant chemotherapy, cystectomy,  neoadjuvant, perioperative How to cite: Shore, Neal D. “Neoadjuvant and Adjuvant Chemotherapy in Bladder Cancer” Grand Rounds in Urology. January 24, 2017. Accessed Dec 2017. https://grandroundsinurology.com/neoadjuvant-adjuvant-chemotherapy-bladder-cancer/.   Transcript Neoadjuvant and Adjuvant Chemotherapy in Bladder Cancer   It was mentioned earlier that bladder cancer has been a terrible red-headed stepchild, and thanks to many of the folks in the room, and who have already presented before me, and I’m honored to be on this...

Read More

Continuing Care for Your Patients with Metastatic CRPC

Dr. Michael S. Cookson presented “Continuing Care for Your Patients with Metastatic CRPC” at the 27th annual International Prostate Cancer Update meeting on Friday, January 27, 2017. Keywords: metastatic castration resistant prostate cancer, Docetaxel, Abiraterone, Enzalutamide, Radium 223, Cabazitaxel How to cite: Cookson, Michael S. “Continuing Care for Your Patients with Metastatic CRPC.” Grand Rounds in Urology. January 27, 2017. Accessed Dec 2017. https://grandroundsinurology.com/continuing-care-patients-metastatic-crpc/. Transcript Continuing Care for Your Patients with Metastatic CRPC I’m going to talk a little bit about sort of pulling things together in terms of the urologist being the primary care giver for men with advanced prostate cancer....

Read More

Join the GRU Community

- Why Join? -